| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-2010-101083 |
| P953 | full work available at URL | https://content.iospress.com/download?id=10.3233/JAD-2010-101083 |
| P698 | PubMed publication ID | 20930294 |
| P50 | author | William R. Markesbery | Q56850445 |
| D Allan Butterfield | Q66912067 | ||
| P2093 | author name string | Jian Cai | |
| William M. Pierce | |||
| Renã A. S. Robinson | |||
| Christopher D. Aluise | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 257-269 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI | |
| P478 | volume | 23 |
| Q37960537 | 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies |
| Q36821506 | 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures |
| Q37111515 | Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression |
| Q37956168 | Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease |
| Q47145007 | Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function |
| Q101051196 | Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila |
| Q27003253 | Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain |
| Q34518584 | Epigenomics of Alzheimer's disease |
| Q34157658 | Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology |
| Q26773657 | Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease |
| Q36970130 | Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder |
| Q38050263 | Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain |
| Q26865358 | Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention |
| Q36539454 | Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain? |
| Q60921210 | Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons |
| Q61800105 | Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders |
| Q55262112 | Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging. |
| Q38016374 | Oxidative damage to RNA in aging and neurodegenerative disorders |
| Q46272723 | Oxidative stress and the amyloid beta peptide in Alzheimer's disease |
| Q58727014 | Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology |
| Q36846943 | Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice |
| Q33765360 | Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome |
| Q42111668 | Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease |
| Q30367032 | Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain. |
| Q30446460 | Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. |
| Q26827320 | The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment |
| Q24618841 | The antioxidant paradox: less paradoxical now? |
| Q40098573 | The diabetic brain and cognition |
| Q35783379 | The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons |
Search more.